PRIMAXIN IV is a Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Imipenem; Cilastatin Sodium.
| Product ID | 0006-3516_25896be0-b49d-43cd-8f90-105327b2ecfe |
| NDC | 0006-3516 |
| Product Type | Human Prescription Drug |
| Proprietary Name | PRIMAXIN IV |
| Generic Name | Imipenem And Cilastatin Sodium |
| Dosage Form | Injection, Powder, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 1985-11-26 |
| Marketing Category | NDA / NDA |
| Application Number | NDA050587 |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | IMIPENEM; CILASTATIN SODIUM |
| Active Ingredient Strength | 500 mg/100mL; mg/100mL |
| Pharm Classes | Carbapenems [CS],Penem Antibacterial [EPC],Dipeptidase Inhibitors [MoA],Renal Dehydropeptidase Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 1985-11-26 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA050587 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1985-11-26 |
| Ingredient | Strength |
|---|---|
| IMIPENEM | 500 mg/100mL |
| SPL SET ID: | f41d8abd-7792-4918-1b93-bd83ea01955e |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 63323-322 | Imipenem and Cilastatin | Imipenem and Cilastatin Sodium |
| 63323-349 | Imipenem and Cilastatin | Imipenem and Cilastatin Sodium |
| 0006-3516 | PRIMAXIN | imipenem and cilastatin sodium |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() PRIMAXIN 73446124 1297360 Live/Registered |
Merck & Co., Inc. 1983-09-30 |